Literature DB >> 15539004

Reducing the incidence of foot ulceration and amputation in diabetes.

Cynthia L Bartus1, David J Margolis.   

Abstract

Diabetes is a common disease that is associated with numerous complications, including foot ulceration and amputation. In diabetic patients, the incidence of foot ulcers ranges from 1.0% to 4.1%, and the incidence of lower-extremity amputations ranges from 2.1 to 13.7 per 1000. Risk factors for developing foot ulcers and subsequent amputation include neuropathy, peripheral vascular disease, and trauma. To reduce these complications, several preventive strategies have been devised, from reducing risk factors to improving treatment and management.

Entities:  

Mesh:

Year:  2004        PMID: 15539004     DOI: 10.1007/s11892-004-0049-x

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  54 in total

1.  Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.

Authors:  H Pham; D G Armstrong; C Harvey; L B Harkless; J M Giurini; A Veves
Journal:  Diabetes Care       Date:  2000-05       Impact factor: 19.112

2.  Factors associated with future amputation among patients undergoing hemodialysis: results from the Dialysis Morbidity and Mortality Study Waves 3 and 4.

Authors:  Ann M O'Hare; Peter Bacchetti; Mark Segal; Chi-yuan Hsu; Kirsten L Johansen
Journal:  Am J Kidney Dis       Date:  2003-01       Impact factor: 8.860

3.  Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.

Authors:  G E Reiber; L Vileikyte; E J Boyko; M del Aguila; D G Smith; L A Lavery; A J Boulton
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

4.  Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study.

Authors:  V Dargis; O Pantelejeva; A Jonushaite; L Vileikyte; A J Boulton
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

5.  Outcomes associated with diabetes-related amputations in The Netherlands and in the state of California, USA.

Authors:  W H Van Houtum; L A Lavery
Journal:  J Intern Med       Date:  1996-10       Impact factor: 8.989

6.  The distribution and severity of diabetic foot disease: a community study with comparison to a non-diabetic group.

Authors:  D P Walters; W Gatling; M A Mullee; R D Hill
Journal:  Diabet Med       Date:  1992-05       Impact factor: 4.359

Review 7.  Patient education for preventing diabetic foot ulceration. A systematic review.

Authors:  Gerlof D Valk; Didi M W Kriegsman; Willem J J Assendelft
Journal:  Endocrinol Metab Clin North Am       Date:  2002-09       Impact factor: 4.741

8.  The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study.

Authors:  S Kumar; H A Ashe; L N Parnell; D J Fernando; C Tsigos; R J Young; J D Ward; A J Boulton
Journal:  Diabet Med       Date:  1994-06       Impact factor: 4.359

Review 9.  Diagnosing and treating diabetic foot infections.

Authors:  Benjamin A Lipsky; Anthony R Berendt; John Embil; Fausto De Lalla
Journal:  Diabetes Metab Res Rev       Date:  2004 May-Jun       Impact factor: 4.876

10.  Risk factors for lower extremity amputation in persons with diabetes.

Authors:  J V Selby; D Zhang
Journal:  Diabetes Care       Date:  1995-04       Impact factor: 19.112

View more
  27 in total

1.  A case of dominant dystrophic epidermolysis bullosa with diabetes mellitus presenting as progressive recalcitrant blisters and erosions.

Authors:  Kio Park; Hajime Nakano; Daisuke Sawamura; Kenji Kabashima; Yoshiki Miyachi
Journal:  Int Wound J       Date:  2013-02-24       Impact factor: 3.315

2.  Diabetic foot care: self reported knowledge and practice among patients attending three tertiary hospital in Nigeria.

Authors:  O O Desalu; F K Salawu; A K Jimoh; A O Adekoya; O A Busari; A B Olokoba
Journal:  Ghana Med J       Date:  2011-06

3.  Melatonin promotes diabetic wound healing in vitro by regulating keratinocyte activity.

Authors:  Ruipeng Song; Lijun Ren; Haoli Ma; Ruijing Hu; Honghong Gao; Li Wang; Xuehui Chen; Zhigang Zhao; Jialin Liu
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

4.  Efficacy and safety of neutral pH superoxidised solution in severe diabetic foot infections.

Authors:  Fermín R Martínez-De Jesús; Antonio Ramos-De la Medina; José María Remes-Troche; David G Armstrong; Stephanie C Wu; Jose Luis Lázaro Martínez; Juan V Beneit-Montesinos
Journal:  Int Wound J       Date:  2007-10-22       Impact factor: 3.315

5.  Fewer major amputations among individuals with diabetes in Finland in 1997-2007: a population-based study.

Authors:  Tuija S Ikonen; Reijo Sund; Maarit Venermo; Klas Winell
Journal:  Diabetes Care       Date:  2010-08-31       Impact factor: 19.112

6.  The redox enzyme p66Shc contributes to diabetes and ischemia-induced delay in cutaneous wound healing.

Authors:  Gian Paolo Fadini; Mattia Albiero; Lisa Menegazzo; Elisa Boscaro; Elisa Pagnin; Elisabetta Iori; Chiara Cosma; Annunziata Lapolla; Vittorio Pengo; Massimo Stendardo; Carlo Agostini; Pier Giuseppe Pelicci; Marco Giorgio; Angelo Avogaro
Journal:  Diabetes       Date:  2010-06-21       Impact factor: 9.461

7.  Dendritic epidermal T cells facilitate wound healing in diabetic mice.

Authors:  Zhongyang Liu; Yingbin Xu; Lei Chen; Julin Xie; Jinming Tang; Jingling Zhao; Bin Shu; Shaohai Qi; Jian Chen; Guangping Liang; Gaoxing Luo; Jun Wu; Weifeng He; Xusheng Liu
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

Review 8.  Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing.

Authors:  Zhao-Jun Liu; Omaida C Velazquez
Journal:  Antioxid Redox Signal       Date:  2008-11       Impact factor: 8.401

9.  Phase I study of H5.020CMV.PDGF-beta to treat venous leg ulcer disease.

Authors:  David J Margolis; Lee M Morris; Maryte Papadopoulos; Linda Weinberg; Jennifer C Filip; Stephanie A Lang; Sachin S Vaikunth; Timothy M Crombleholme
Journal:  Mol Ther       Date:  2009-07-28       Impact factor: 11.454

Review 10.  Management and prevention of diabetic foot ulcers and infections: a health economic review.

Authors:  Ivy Chow; Elkin V Lemos; Thomas R Einarson
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.